Sudoscan partners with Lovell to expand federal access to nerve-fiber testing

Sudoscan and Lovell Government Services have formed a partnership to widen access to SUDOSCAN® and Smart Electrodes across VA, DoD and Indian Health Service facilities. The deal is meant to streamline federal purchasing and make the non-invasive test more available to providers serving veterans, service members and other patients.

Why it matters: - The partnership gives federal healthcare systems another path to buy SUDOSCAN®, a device used to assess small nerve fiber function. - Lovell Government Services will act as Sudoscan’s Service-Disabled Veteran-Owned Small Business vendor, which can help federal agencies meet SDVOSB procurement goals. - Wider access could help veterans, service members and other federal patients get faster screening for small nerve fiber dysfunction.

What happened: - Sudoscan and Lovell Government Services announced a partnership on Sept. 2, 2026, to expand access to SUDOSCAN® and Smart Electrodes. - The agreement covers federal healthcare systems including the Veterans Health Administration, Military Health System and Indian Health Service. - Lovell will help make Sudoscan’s technology more accessible through government contracting systems.

The details: - SUDOSCAN® is a non-invasive medical device that assesses sweat gland function. - The test is designed to provide objective information about small nerve fiber function. - The system uses four electrodes, with patients placing their hands and bare feet on the device. - The device stimulates sweat glands and measures the response to evaluate small nerve fibers, including C fibers. - The assessment takes under three minutes. - Sudoscan products are pending addition to or available on select federal procurement channels, including the Department of Veterans Affairs Federal Supply Schedule, GSA Advantage, the Defense Logistics Agency’s Electronic Catalog and the Department of Defense’s Distribution and Pricing Agreement. - Availability through Lovell’s contract vehicles is intended to streamline federal acquisition.

Between the lines: - The partnership fits a broader push to move niche medical technologies into federal buying channels more quickly. - The contracting structure may matter as much as the device itself, because federal access often depends on procurement status, not just clinical usefulness. - The announcement frames SUDOSCAN® as a fast screening tool for earlier detection, but the release does not provide clinical study data here.

What's next: - Sudoscan products may be added to more federal purchasing lists and catalogs through Lovell’s contract vehicles. - The companies say the arrangement should broaden access for providers serving veterans, active-duty personnel and other federal patients. - More information is available at Sudoscan and Lovell Government Services.